Alaunos Therapeutics, Inc. Common Stock (NASDAQ: TCRT) last traded at $1.76, down 1.13% on the session. The quote above updates while this page is open; the figures below are drawn from Alaunos Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Alaunos Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker TCRT. Its market capitalisation is $4.47 million.
Valuation measures for Alaunos Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $4.47M |
|---|---|
| Enterprise value | $5.21M |
| Price / sales | 1490.41 |
| Price / book | 6.86 |
| Beta | 1.16 |
Trailing-twelve-month figures tagged in Alaunos Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $3.0K |
|---|---|
| Net income (TTM) | -$4.01M |
| EPS (TTM) | -$1.90 |
| Operating margin | -135266.67% |
| Return on equity | -615.03% |
| Cash | $124.0K |
Range and volume for TCRT over the past 52 weeks.
| 52-week high | $4.59 |
|---|---|
| 52-week low | $1.73 |
| Volume | 15.1K |
| Average volume | 15.5K |
| Previous close | $1.78 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.